Brief: Piramal Pharma To Reduce GHG Emissions By 2030
17/09/2024 05:45
Sept 17 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* PIRAMAL PHARMA - RECEIVED SBTI APPROVAL FOR COMMITMENT TO
REDUCE
SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030
Source text for Eikon: ID:nBSEccwrM7
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington